Atlas Trials

[14C] Study to Investigate the Mass Balance and Biotransformation of WPV01 in Healthy Adult Chinese Male Participants

Clinical trial NCT07080658 · COMPLETED

Trial details

NCT number
NCT07080658
Sponsor
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2023-07-23
Primary completion
2023-07-24
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.